Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)

NCT02974504 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes

Interventions

DRUG: evogliptin
DRUG: Linagliptin

Sponsor

Dong-A ST Co., Ltd.